Bruker Launches the VERTEX NEO Ultra
Setting New Standard for Benchtop Vacuum FT-IR Spectroscopy in Advanced Research.
New flagship spectrometer enables automated multi-detector flexibility for high-throughput scientific applications.
BILLERICA, Massachusetts - November 20, 2025 - Bruker Corporation (Nasdaq: BRKR) today announced the launch of the VERTEX NEO Ultra, its most advanced and versatile benchtop vacuum Fourier-Transform Infrared (FT-IR) spectrometer. Building on the VERTEX NEO platform, NEO Ultra combines high spectral performance with full automation to deliver faster, more reliable results in academic and industrial research.
The NEO Ultra helps scientists achieve accurate, reproducible results in challenging research areas such as catalysis, space technology, and photonics. True vacuum eliminates CO₂ and H₂O interference, while automated switching between sources, detectors, and beam splitters maximizes uptime and flexibility. MultiTect™ technology supports up to six detectors, adapting instantly to different experiments. The UltraScan™ interferometer delivers precise measurements with 0.04 cm⁻¹ resolution across a wide spectral range, and time-resolved spectroscopy captures ultrafast dynamics. The integrated Vacuum Platinum ATR streamlines sample handling for efficient ATR measurements in ambient lab air.
Stefan Heißler, Head of Molecular Spectroscopy Lab, Institute of Functional Interfaces at the Karlsruhe Institute of Technology (KIT), commented: “I’m impressed by the new FT-IR system. The MultiTect unit marks a major step forward in automating multispectral experiments. The signal-to-noise ratio, even with a DTGS detector in a basic transmission setup, is noticeably improved. I appreciate the sleek yet robust design, and the clear product philosophy: INVENIO for purge, and VERTEX for vacuum measurements. It’s great to see all trusted VERTEX features preserved.”
“With our NEO Ultra flagship, Bruker delivers new and enhanced capabilities that empower researchers around the globe to push the boundaries of advanced FT-IR research and applications. It reflects our commitment to innovation and to supporting the scientific community with tools that accelerate discovery,” said Dr. Andreas Kamlowski, President of the Bruker Optics Division.
About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)
Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nano analysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.
Media Contact
Natalie Spahl
Head of Global Marketing
Bruker Optics Division
T: +49 173 9662425
E: Natalie.spahl@bruker.com